Italy’s Angelini Said to Explore Acquisition of Catalyst Pharma

Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.